Skip to content

Reduction Mammaplasty and Improved Quality of Life

Reduction Mammaplasty Safely Increases the Quality of Life in Patients With Mammary Hypetrophy.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02769559
Acronym
MammaRed
Enrollment
52
Registered
2016-05-11
Start date
2000-01-31
Completion date
2016-05-31
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macromastia, Quality of Life, Signs and Symptoms

Brief summary

The data gathered here will be used to evaluate the efficacy and safety of the mammary reduction in patients with macromastia.

Detailed description

The data was gathered using retrospective and follow-up prospective study of a group of patients, consisting of adult women that underwent a breast reduction surgery at the Clinic of Plastic, Reconstructive and Aesthetic Surgery Faculty of Comenius University and at the University Hospital in Bratislava, Ružinov, during the time period between 2000 until May 2014. The data concerning the quality of life of these patients was gathered by using the globally standardized questionnaire Breast Q questionnaire© with the separate software system evaluation tool QScore©. The statistical analysis was conducted using GraphpadPrism program v. 6.01. The total number of respondents consisted of 52 people who were followed-up for up to 12 years.

Interventions

Surgical removal of excess breast tissue

Sponsors

Comenius University
CollaboratorOTHER
University Hospital Bratislava
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 63 Years
Healthy volunteers
No

Inclusion criteria

* above 18 years * macromastia on clinical examination * fulfilled Breast Q Questionnaire prior to surgery and after surgery * signed informed consent

Exclusion criteria

* failed to sign informed consent * failed to fill the Breast Q Questionnaire * patients with altered mental status and behaviour * patients with concomitant breast disease, or with previous breast interventions as are radiotherapy, surgery, or breast cancer

Design outcomes

Primary

MeasureTime frameDescription
Quality of life2000-2014Questionnaires about quality of life before and up to 12 years after surgery

Secondary

MeasureTime frameDescription
Rate of adverse outcomes2000-2014Evaluation of rate and types of negative outcomes up to 12 years after elective reduction surgery

Countries

Slovakia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026